5/20/2022 5:42:40 AM
LumiraDx Receives WHO Emergency Use Listing For SARS-CoV-2 Ag Test
5/19/2022 9:01:46 AM
LumiraDx Announces SARS-CoV-2 Ag Ultra Test Achieved CE Marking
3/10/2022 6:11:03 AM
LumiraDx Q4 Loss Per Share $0.15 Vs Loss $0.51 Last Year
1/14/2022 6:20:29 AM
LumiraDx Lab Analysis Confirms COVID-19 Antigen Test Detects Omicron Variant
1/11/2022 6:35:30 AM
LumiraDx Says C-reactive Protein Test Achieves CE Marking
12/23/2021 6:07:49 AM
LumiraDx: SARS-CoV-2 & Flu A/B Antigen Test Achieves CE Marking
12/1/2021 8:29:07 AM
FDA Reissues LumiraDx Fast Lab Solutions' EUA For SARS CoV-2 RNA STAR Complete Molecular Reagents
11/10/2021 6:23:15 AM
LumiraDx Reports Q3 Net Income Of $84.8 Mln Or $0.46/shr